๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Unresectable Stage III Non-small Cell Lung Cancer

Study of Antitumor Immune Response After cCRT and IO Treatment in Non-resectable III Stage NSCLC Patients NCT06634199n/a22 sites๐Ÿ“ Ferrol๐Ÿ“ Alicante๐Ÿ“ Badalona Fundaciรณn GECP ยท Tests: Durvalumab Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC) NCT07149649Phase 2, Phase 311 sites๐Ÿ“ Aarau๐Ÿ“ Aarau๐Ÿ“ Baden Swiss Cancer Institute ยท Tests: Magnesiocard, Magnesium Diasporal, Microcrystalline cellulose, Isotonic saline solution 0.9% Adjuvant Chemotherapy +/- Cemiplimab and Sequential Hypofractionated Radiotherapy in Unfit or Elderly Patients With Stage III Lung Cancer NCT06656598Phase 225 sites๐Ÿ“ Angers๐Ÿ“ Angers๐Ÿ“ Avignon Intergroupe Francophone de Cancerologie Thoracique ยท Tests: Carboplatin, Paclitaxel, Cemiplimab, Curative hypofractionated radiotherapy, Cemiplimab (maintenance) A Phase I Dose Escalation and Dose Expansion Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Durvalumab NCT07391670Phase 119 sites๐Ÿ“ Fitzroy๐Ÿ“ St Albans๐Ÿ“ Woolloongabba AstraZeneca ยท Tests: SC durvalumab + rHu, IV durvalumab, Tremelimumab Risk-adapted, Proteomic-guided Systemic Therapy for Previously Untreated Advanced Non-small Cell Lung Cancer NCT07250477Phase 24 sites๐Ÿ“ Chico๐Ÿ“ Marysville๐Ÿ“ Sacramento University of California, Davis ยท Tests: Systemic (ICI)-based therapy informed by the PROphet CB assay and the CARG-TT assessment., Standard of Care Neoadjuvant IBI308, Bevacizumab, Plus Pemetrexed and Carboplatin Followed by Surgery in Unresectable Stage III NSCLC NCT03872661Phase 21 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: IBI308, Bevacizumab, Pemetrexed, Carboplatin, Thoracic surgery A Phase III Study to Assess the Effects of Almonertinib Following Chemoradiation in Patients With Stage III Unresectable Non-small Cell Lung Cancer NCT04951635Phase 31 site๐Ÿ“ Ji'nan Jiangsu Hansoh Pharmaceutical Co., Ltd. ยท Tests: Almonertinib, Placebo Almonertinib PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC NCT06102057Phase 211 sites๐Ÿ“ Dresden๐Ÿ“ Essen๐Ÿ“ Freiburg im Breisgau TheraOp ยท Tests: standard Radiotherapy, Chemotherapy, Immunotherapy, Experimental Radiotherapy Induction Chemoimmunotherapy in Combination With Chemoradiotherapy and Consolidation Immunotherapy in Unresectable Locally Advanced Non-Small Cell Lung Cancer NCT07632365Phase 1, Phase 21 site๐Ÿ“ Shanghai Shanghai Chest Hospital ยท Tests: Induction chemoimmunotherapy, Concurrent chemoradiotherapy (cCRT), consolidation immunotherapy Targeted Induction Therapy for Stage III Unresectable EGFR Mutant Positive NSCLC NCT07742332Phase 21 site๐Ÿ“ Shanghai Peng Zhang ยท Tests: Fumetinib combined platinum-based double chemotherapy, Concurrent Radiochemotherapy A Study Comparing BL-B01D1 in Combination With Osimertinib Versus Osimertinib Alone in Patients With Locally Advanced, Unresectable EGFR-mutated Non-small Cell Lung Cancer(Stage III) Whose Disease Has Not Progressed Following Definitive Platinum-based Chemoradiation Therapy(PANKU-Lung08) NCT07640789Phase 31 site๐Ÿ“ Jinan Sichuan Baili Pharmaceutical Co., Ltd. ยท Tests: BL-B01D1, Osimertinib PALACE: Cemiplimab Trial According to ctDNA Levels NCT06917573Phase 220 sites๐Ÿ“ Alicante๐Ÿ“ Elche๐Ÿ“ Badalona Fundaciรณn GECP ยท Tests: Cemiplimab, Carboplatin, Paclitaxel Chemoradiotherapy With Surgery Followed by Consolidation Durvalumab NCT06908070Phase 41 site๐Ÿ“ Amsterdam Idris Bahce ยท Tests: Consolidation durvalumab A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) NCT07154290Phase 218 sites๐Ÿ“ Birmingham๐Ÿ“ Goodyear๐Ÿ“ Irvine Regeneron Pharmaceuticals ยท Tests: Ubamatamab, Marlotamig, Sarilumab IBI363 (PD-1/IL-2ฮฑ-bias) in Combination With Chemotherapy as Neoadjuvant Therapy in Initially Unresectable Stage III Non-Small Cell Lung Cancer NCT07408635Phase 21 site๐Ÿ“ Shanghai Shanghai Pulmonary Hospital, Shanghai, China ยท Tests: IBI363 + Chemotherapy Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer NCT05098210Phase 11 site๐Ÿ“ Seattle Fred Hutchinson Cancer Center ยท Tests: Neoantigen Peptide Vaccine, Nivolumab, Poly ICLC, Echocardiography Test, Multigated Acquisition Scan A Study of AK104 in Subjects With Unresectable Locally Advanced NSCLC NCT06617416Phase 31 site๐Ÿ“ Jinan Akeso ยท Tests: Cadonilimab (AK104), Sugemalimab Afatinib Combined With Chemotherapy as Conversion Therapy in Unresectable EGFR Sensitive Mutation-positive Stage III NSCLC NCT06709859Phase 21 site๐Ÿ“ Jinan Shandong Public Health Clinical Center ยท Tests: Afatinib plus chemotherapy as conversion treatment Quick Start Durvalumab Following Chemoradiation for Stage III Nonsmall Cell Lung Cancer NCT05696782Phase 22 sites๐Ÿ“ Charlotte๐Ÿ“ Winston-Salem Wake Forest University Health Sciences ยท Tests: Durvalumab, the EORTC Core Quality of Life Questionnaire (EORTC QLQ-C30), COPD Assessment Test (CAT), Modified Medical โ€ฆ Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy NCT05398094Phase 220 sites๐Ÿ“ Alicante๐Ÿ“ Badalona๐Ÿ“ Barcelona Fundaciรณn GECP ยท Tests: Sotorasib A Study to Evaluate GFH375 Versus Docetaxel in Participants With Non-Small Cell Lung Cancer With KRAS G12D Mutation NCT07668752Phase 31 site๐Ÿ“ Shanghai Genfleet Therapeutics (Shanghai) Inc. ยท Tests: GFH375, Docetaxel A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201) NCT07361497Phase 3260 sites๐Ÿ“ Daphne๐Ÿ“ Golden๐Ÿ“ Newark Bristol-Myers Squibb ยท Tests: Pumitamig, Durvalumab A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC) NCT06667908Phase 244 sites๐Ÿ“ La Jolla๐Ÿ“ Farmington๐Ÿ“ New Haven Johnson & Johnson Enterprise Innovation Inc. ยท Tests: JNJ-90301900, Durvalumab, Concurrent Chemo/Radiation Therapy (cCRT), Concurrent Chemo/Radiation Therapy (cCRT): Carboplโ€ฆ A Trial of Sugemalimab and Chemotherapy in Unresectable Stage III NSCLC NCT05940532Phase 21 site๐Ÿ“ Changsha Hunan Cancer Hospital ยท Tests: Sugemalimab and Chemotherapy Tislelizumab Combined With Recombinant Human Endostatin Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer. NCT06617936Phase 21 site๐Ÿ“ Jinan Hua Zhang ยท Tests: neoadjuvant therapy:Tislelizumab With Recombinant human endostatin combined with Chemotherapy, surgery, Adjuvant therapโ€ฆ A Phase II Trial to Evaluate the Efficiency and Safety of Serplulimab Plus Chemotherapy as Conversion Therapy in NSCLC NCT05837052Phase 21 site๐Ÿ“ Hangzhou Zhejiang University ยท Tests: serplulimab plus chemotherapy as conversion treatment Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program NCT06265285Phase 21 site๐Ÿ“ Jacksonville Mayo Clinic ยท Tests: Home Health Encounter, Nivolumab, Patient Monitoring, Questionnaire Administration Hypofractionated Chemoradiotherapy With Tislelizumab and Surufatinib for Unresectable Stage III NSCLC NCT07609121Phase 21 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: Radiotherapy, Concurrent chemotherapy, Tislelizumab, Surufatinib A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer NCT05361174Phase 1, Phase 211 sites๐Ÿ“ Los Angeles๐Ÿ“ Miami๐Ÿ“ Orlando Iovance Biotherapeutics, Inc. ยท Tests: IOV-4001 Neoadjuvant Umbrella Trial for Patients With Unresectable Stage III NSCLC Harboring Rare Mutations. NCT06563999Phase 21 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: Sunvozertinib, Crizotinib, Pralsetinib, Larotrectinib, Savolitinib
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy